Publications | Lund University Publications

1 – 8 of 8

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Dreyling%2C+M.%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Dreyling%2C+M.%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2025
Mark Peripheral T- and natural killer-cell lymphomas : ESMO–EHA Clinical Practice Guideline for diagnosis, treatment and follow-up ^☆
d'Amore, F. ; Federico, M. ; de Leval, L. ; Ellin, F. ^LU ; Hermine, O. ; Kim, W. S. ; Lemonnier, F. ; Vermaat, J. S.P. ; Wulf, G. and Buske, C. , et al. (2025) In Annals of Oncology 36(6). p.626-644
- Contribution to journal › Article
2024
Mark Primary central nervous system lymphomas : EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up^☆
Ferreri, A. J.M. ; Illerhaus, G. ; Doorduijn, J. K. ; Auer, D. P. ; Bromberg, J. E.C. ; Calimeri, T. ; Cwynarski, K. ; Fox, C. P. ; Hoang-Xuan, K. and Malaise, D. , et al. (2024) In Annals of Oncology 35(6). p.491-507
- Contribution to journal › Article
2022
Mark The EHA Research Roadmap: Malignant Lymphoid Diseases
Dreyling, M. ; Jerkeman, M. ^LU and Salles, G. (2022) In HemaSphere 6(6). p.726-726
- Contribution to journal › Article
2021
Mark Newly diagnosed and relapsed follicular lymphoma : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Dreyling, M. ; Ghielmini, M. ; Rule, S. ; Salles, G. ; Ladetto, M. ; Tonino, S. H. ; Herfarth, K. ; Seymour, J. F. and Jerkeman, M. ^LU (2021) In Annals of oncology : official journal of the European Society for Medical Oncology 32(3). p.298-308
- Contribution to journal › Article
2018
Mark Ibrutinib versus temsirolimus : 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study
Rule, S. ; Jurczak, W. ; Jerkeman, M. ^LU ; Rusconi, C. ; Trneny, M. ; Offner, F. ; Caballero, D. ; Joao, C. ; Witzens-Harig, M. and Hess, G. , et al. (2018) In Leukemia 32(8). p.1799-1803
- Contribution to journal › Article
2017
Mark Targeting of B-cell receptor signalling in B-cell malignancies
Jerkeman, M. ^LU ; Hallek, M ; Dreyling, M ; Thieblemont, Catherine ; Kimby, E and Staudt, L. (2017) In Journal of Internal Medicine 282(5). p.415-428
- Contribution to journal › Scientific review
Mark Newly diagnosed and relapsed mantle cell lymphoma : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Dreyling, M ; Campo, E ; Hermine, O ; Jerkeman, M. ^LU ; Le Gouill, S. ; Rule, Simon ; Shpilberg, Ofer ; Walewski, J. ^LU and Ladetto, M. (2017) In Annals of Oncology 28. p.62-71
- Contribution to journal › Article
2015
Mark Total body irradiation after high-dose cytarabine in mantle cell lymphoma: A comparison of Nordic MCL2, HOVON-45, and European MCLYounger trials.
Hoster, E ; Geisler, C H ; Doorduijn, J ; van der Holt, B ; Walewski, J ; Bloehdorn, J ; Ribrag, V ; Salles, G ; Hallek, M and Pott, C , et al. (2015) In Leukemia
- Contribution to journal › Article

your query:: Remove author: Dreyling, M.